Related Experiment Video
Updated: Apr 20, 2026
07:27
A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting
Published on: May 16, 2013
19.2K
Erythrocyte-platelet interaction in uncomplicated pregnancy
Albe C Swanepoel1, Etheresia Pretorius1
1Department of Physiology,School of Medicine, Faculty of Health Sciences,University of Pretoria,Private Bag x323;Arcadia 0007,South Africa.
Summary
Pregnancy alters blood cells, with unique interactions between red blood cells (RBCs) and platelets observed. These RBC-platelet interactions may explain pregnancy-related blood changes and hypercoagulability.
Area of Science:
- Hematology
- Obstetrics
- Cell Biology
Background:
- Pregnancy involves significant hematopoietic system changes.
- Erythrocytes (red blood cells, RBCs) and platelets are crucial for coagulation.
- RBC-platelet interactions may underlie pregnancy-associated hypercoagulability.
Purpose of the Study:
- To investigate RBC-platelet interactions during uncomplicated pregnancy.
- To explore the role of these interactions in pregnancy-related hematological changes.
Main Methods:
- Literature review on RBC and platelet membrane interactions.
- Scanning electron microscopy of blood smears from 90 pregnant individuals.
- Analysis of RBC-platelet interactions across different pregnancy stages.
Main Results:
- Observed pregnancy-specific interactions between RBCs and platelets.
- Platelets exhibited spreading and pseudopodia formation with RBCs.
- Increased estrogen and fibrinogen concentrations may drive these interactions.
Conclusions:
- Specific RBC-platelet interactions occur during pregnancy.
- These interactions may contribute to the hypercoagulable state in pregnancy.
- RBC-platelet interactions might play a role in gestational thrombocytopenia.
Related Concept Videos
01:22Formation of the Platelet Plug
11.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
11.1K
01:18Structure and Function of Platelets
7.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
7.1K
01:19Rh Blood Group
4.6K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.6K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
01:24Factors Affecting Erythropoiesis
9.2K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
9.2K
01:27Disorders of Erythrocytes
3.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
3.0K